Malvern Biopharm Company Teams With Australian Institute

Wednesday, Jan 22, 2014  |  Updated 12:04 PM EDT
View Comments (
)
|
Email
|
Print
Malvern Biopharm Company Teams With Australian Institute

clipart.com

advertisement

TetraLogic Pharmaceuticals Corp. has entered into a licensing deal and research collaboration with an Australian research institute.

Financial terms of the deal with the Walter and Eliza Hall Institute of Medical Research were not disclosed.

The focus of the deal is TetraLogic’s experimental viral infection therapy birinapant, which in preclinical studies with rats conducted by the Hall Institute demonstrated effectiveness in combating the hepatitis B virus.

Read more at PBJ.com

Get the latest headlines sent to your inbox!
View Comments (
)
|
Email
|
Print
Leave Comments
What's New
FlyeredUp: Win 2 Tickets to Flyers Playoff Game
Win two tickets to the first... Read more
Follow Us
Sign up to receive news and updates that matter to you.
Send Us Your Story Tips
Check Out